Evidence map›Paper›PMID 41761111›Full record

ReviewBMC neurology2026

Clinical and molecular characterization of Krabbe disease in Iranian patients: case report and literature review.

Parnia Asgari, Iman Elahi Vahed, Sahand Tehrani Fateh, Farzad Hashemi-Gorji, Mohammad-Reza Ghasemi, Ali Mardi, Seyed Hassan Tonekaboni, Mohammad Miryounesi, Shadab Salehpour

Abstract readCase ReportsReview
In one paragraph

Review in BMC neurology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Parnia Asgari *School of Medicine, Islamic Azad University Tehran Medical sciences, Tehran, Iran.
Iman Elahi Vahed *School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Sahand Tehrani Fateh *School of Medicine, Tehran University of Medical Sciences, Tehran, Iran.
Farzad Hashemi-GorjiGenomic Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Mohammad-Reza GhasemiDepartment of Medical Genetics, Faculty of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Ali MardiCenter for Comprehensive Genetic Services, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Seyed Hassan TonekaboniPediatric Neurology Excellence Center, Pediatric Neurology Department, Mofid Children Hospital, Faculty of Medicine, Shahid Beheshti University of Medical Sciences (SBMU), Tehran, Iran.
Mohammad MiryounesiGenomic Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran. miryounesi@gmail.com.
Shadab SalehpourDepartment of Pediatrics, Clinical Research Development Unit, Loghman Hakim Hospital, Shahid Beheshti University of Medical Sciences, Tehran, Iran. shadab.salehpour@gmail.com.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Krabbe disease (KD, OMIM #245200) is a rare autosomal recessive lysosomal storage disorder characterized by severe demyelination affecting both the central and peripheral nervous systems. Here we report the clinical and molecular findings of two unrelated Iranian patients with KD, originating from consanguineous families. Genetic analysis was initially performed using whole-exome sequencing (WES), then validated by Sanger sequencing. WES identified a novel homozygous variant in the GALC, c.836T > G (p.L279X), in patient-1. In patient-2, WES detected a previously reported homozygous variant, c.578T > C (p.I193T), in the GALC. Sanger sequencing confirmed homozygosity of these variants in the affected patients and heterozygosity in their parents. The affected brother of patient-2 was also homozygous for the variant c.578T > C. The pathogenicity of the detected variants was supported by various lines of evidence, including in silico predictive tools, segregation analysis, and population genetic databases frequency. Our findings expand the mutational spectrum of GALC and highlight the clinical heterogeneity of KD. Morover, these finding contribute to improved genotype-phenotype correlations, which are essential for accurate diagnosis, prognostic valuation, and genetic counseling.

Indexed as

GalactosylceramidaseLeukodystrophy, Globoid CellExome SequencingHomozygoteHumansInfantIranMaleMutationPedigreeYoung AdultGalactosylceramidaseGALC geneKrabbe diseaseNovel variantWhole exome sequencing (WES(

Identifiers

PMID41761111
PMCPMC13040988

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.